Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 2
2009 2
2011 1
2012 1
2013 1
2014 1
2015 1
2017 1
2018 1
2019 1
2020 7
2021 9
2022 15
2023 9
2024 8
2025 13
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy.
Kirstein A, Ionascu D, Lamba MAS, Ruffolo BM, Crail KJ, Mascia AE, Sertorio MG, Hinrichs BH, Zender C, Lehn MA, Wise-Draper TM, Perentesis JP, Zheng Y, Wells SI. Kirstein A, et al. Among authors: wise draper tm. Clin Transl Radiat Oncol. 2025 Sep 15;56:101046. doi: 10.1016/j.ctro.2025.101046. eCollection 2026 Jan. Clin Transl Radiat Oncol. 2025. PMID: 41049395 Free PMC article.
Preclinical Evaluation of the Efficacy of a Cyclin-dependent Kinase Inhibitor Ribociclib in Combination with Letrozole Against Patient-Derived Glioblastoma Cells.
Gadgil SN, Karve AS, Gudelsky GA, Gabani BB, Medvedovic M, Kulkarni SP, Phoenix TN, Plas DR, Wise-Draper TM, Sengupta S, Dasgupta B, Yogendran L, Desai PB. Gadgil SN, et al. Among authors: wise draper tm. Mol Cancer Ther. 2025 Sep 25. doi: 10.1158/1535-7163.MCT-25-0277. Online ahead of print. Mol Cancer Ther. 2025. PMID: 40994426
Milademetan in Advanced Solid Tumors with MDM2 Amplification and Wild-type TP53: Preclinical and Phase II Clinical Trial Results.
Dumbrava EE, Stinchcombe TE, Gounder M, Cote GM, Hanna GJ, Sumrall B, Wise-Draper TM, Kanaan M, Duffy S, Sumey C, Cobb P, Forbes A, Beckmann AG, Schadt EE, Ku N, Tirunagaru VG, Singh K, Pei X, Xu F, Doebele RC, Chen CT. Dumbrava EE, et al. Among authors: wise draper tm. Clin Cancer Res. 2025 Oct 15;31(20):4255-4264. doi: 10.1158/1078-0432.CCR-25-0762. Clin Cancer Res. 2025. PMID: 40788172 Free PMC article. Clinical Trial.
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors.
Milhem MM, Wise-Draper TM, Chandra S, Hanna GJ, Laux DE, Medina TM, Ansstas G, Daud A, Kelly CM, O'Day SJ, Perez CA, Wong MK, Friedlander PA, Kristedja TS, Burgess MA, Cowey CL, Hanks BA, Weight RM, Daniel WL, Feltner DE, Mix S, Sindelar L, Bexon AS, Bexon MF, Michel RE, Bhatia S. Milhem MM, et al. Among authors: wise draper tm. J Immunother Cancer. 2025 Jul 25;13(7):e011651. doi: 10.1136/jitc-2025-011651. J Immunother Cancer. 2025. PMID: 40713179 Free PMC article. Clinical Trial.
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).
Wong MK, Milhem MM, Sacco JJ, Michels J, In GK, Muñoz Couselo E, Schadendorf D, Beasley GM, Niu J, Chmielowski B, Wise-Draper TM, Bowles TL, Tsai KK, Lebbé C, Gaudy-Marqueste C, Middleton MR, Skolariki A, Samson A, Chesney JA, VanderWalde AM, Zakharia Y, Harrington KJ, Appleton E, Bommareddy PK, Zhu J, Viana M, Hou JW, Coffin RS, Robert C. Wong MK, et al. Among authors: wise draper tm. J Clin Oncol. 2025 Jul 8:JCO2501346. doi: 10.1200/JCO-25-01346. Online ahead of print. J Clin Oncol. 2025. PMID: 40627813
Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers.
Hoskins EL, Vella R, Reeser JW, Wing MR, Samorodnitsky E, Turkoglu A, Stein L, Breuning E, Risch ZA, Hernandez-Sanchez WM, Yu L, Churchman M, Single N, Chahoud J, Jimeno A, Cavnar MJ, Reilley M, Scaife C, Nepple KG, Phan M, Schneider B, Edge S, Salhia B, Leiser A, Wise-Draper TM, Wendt MK, Roychowdhury S. Hoskins EL, et al. Among authors: wise draper tm. NPJ Precis Oncol. 2025 Jul 3;9(1):221. doi: 10.1038/s41698-025-00889-7. NPJ Precis Oncol. 2025. PMID: 40610725 Free PMC article.
71 results